Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Interference with SUMOylation decreases FOXL2 transactivation. by Adrien Georges (201474)

Complex I inhibitor decreases ROS level by Zheng Li (26302)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Microglia-conditioned medium decreases NPC viability. by Johanna Mäkelä (223358)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

High resolution structures visible with the 25 nm zone plate objective. by Kamal L. Nahas (13014698)

“…<p>139 CryoSXT tomograms were recorded from 107 cells using a 25 nm zone plate objective and several structures that were unrelated to HSV-1 infection were observed, including some that were not visible using the 40 nm zone plate objective. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

TWEAK decreases the mitochondrial membrane potential of keratinocytes. by Sanaa Sabour Alaoui (329300)

Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

“…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”